Infusion Therapy Devices Market Summary

• The Global Infusion Therapy Devices Market is estimated to grow at a CAGR of 6.56% during the forecast period from 2025 to 2032.
• Global Infusion Therapy Devices Market Size is expected to reach USD 77.65 billion by 2032.
• The surge in demand for Infusion Therapy Devices is predominantly driven by critical factors such as the escalating Prevalence of chronic disorders like diabetes and cancer. With infusion therapy devices encompassing a broad spectrum of clinical treatments, coupled with a notable increase in product launches, the market is experiencing a significant upswing.

Key Market Trends & Insights

• The leading Infusion Therapy Devices Companies such as Fresenius Kabi AG, Ossila, Ace-medical, ICU Medical, Chmyx Inc., Mindray, Baxter, Becton, Dickinson and Company, Micrel Medical Devices SA, AKAS Infusions, Narang Medical Limited, Monidor Oy, Smiths Group plc, B. Braun SE, Trivitron Healthcare, Eitan Medical, and Others.
• Among all the regions, North America is projected to dominate the Infusion Therapy Devices market in 2023, buoyed by its advanced healthcare infrastructure and a high incidence of chronic diseases such as diabetes, cancer, and arthritis.
• The North America's Infusion Therapy Devices market growth is further supported by continual technological advancements, the presence of major industry players, and a dynamic market environment conducive to product development and launches.

Infusion Therapy Devices Market Size & Forecast

• 2025 Market Size: USD XX Million
• 2032 Projected Market Size: USD 77.65 billion
• CAGR (2025-2032): CAGR of 6.56%
• North America: Largest market in 2025

Factors Contributing to the Rise in Growth of the Infusion Therapy Devices Market

• Rising prevalence of chronic diseases and oncology treatments
  Conditions such as cancer, autoimmune disorders, diabetes complications and complex infusions (biologics, immunotherapies) increase the clinical need for IV and subcutaneous infusion devices—driving baseline demand for pumps, disposables, and infusion services.

• Aging population and longer survival with complex care needs
  A growing geriatric cohort with multiple comorbidities requires long-term, sometimes continuous, infusions (nutritional, hydration, antibiotics, pain control), increasing device utilization and home-care delivery.

• Shift of care from hospitals to home and ambulatory infusion centers
  Cost pressures, patient preference, and improved safety of ambulatory/home infusion models have moved many infusions out of inpatient settings—spurring demand for portable/ambulatory pumps, home infusion infrastructure, and remote monitoring.

• Therapeutic innovation (new biologics, CAR-T, antibody–drug conjugates, complex regimens)
  A high share of recent specialty-drug approvals and pipeline agents require infusion or clinic-administered delivery, creating new, recurring device and service revenue streams. Market analyses and provider surveys point to therapeutic innovation as a major long-term growth engine.

• Technology advances: smarter pumps, connectivity, integration with EHR/RPM and AI
  Next-gen infusion pumps with dose-error reduction software, wireless connectivity, EHR integration, analytics and automated alerts improve safety and enable value-based care models — prompting hospital and home providers to upgrade equipment.

• Reimbursement, policy and cost-savings incentives
  Expanded reimbursement for home infusion, bundled-payment models and payers’ interest in lowering inpatient costs make home/ambulatory infusion financially attractive to providers and payers. These policy/economic drivers accelerate market uptake.

• Supply-chain scale, manufacturing & regional market expansion
  Improved manufacturing capacity (including regional manufacturers gaining regulatory access) and investment in distribution networks have reduced costs and improved availability—particularly in emerging markets where access to infusion therapy has been increasing.

• Investor interest, consolidation and M&A activity
  Strong VC funding and strategic acquisitions in infusion services, device makers and home-care providers have injected capital for scale, product development, and national rollouts—accelerating commercialization.

Infusion Therapy Devices Market By Product Type (Syringe Infusion Pumps, Large Volume Pumps, Elastomeric Pumps, And Others), Mobility (Portable Infusion Pumps, And Stationary Infusion Pumps), Application (Multiple Sclerosis, Diabetes, Rheumatoid Arthritis, Cancer, And Others), End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Homecare And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady cagr forecast till 2030 owing to rise in the prevalence of chronic disorders and increasing clinical applications of infusion therapy devices.

The Global Infusion Therapy Devices Market is estimated to grow at a CAGR of 6.56% during the forecast period from 2025 to 2032 to reach USD 77.65 billion by 2032. The surge in demand for Infusion Therapy Devices is predominantly driven by critical factors such as the escalating Prevalence of chronic disorders like diabetes and cancer. With infusion therapy devices encompassing a broad spectrum of clinical treatments, coupled with a notable increase in product launches, the market is experiencing a significant upswing. These factors collectively contribute to fostering a positive trajectory for the growth of the infusion therapy devices market throughout the forecast period spanning from 2025 to 2032.

What are the latest Infusion Therapy Devices Market Dynamics?

The global prevalence of diabetes and cancer is driving significant growth in the market for infusion therapy devices. According to the International Diabetes Federation (IDF), in 2021, an estimated 537 million adults aged 20-79 were living with diabetes. This number is projected to rise to 643 million by 2030 and 783 million by 2045. Additionally, 541 million individuals were reported to have Impaired Glucose Tolerance (IGT), putting them at high risk of developing Type 2 diabetes. Notably, three-quarters of adults with diabetes reside in low- and middle-income countries, where the need for advanced medical devices like insulin pumps is crucial. These devices are essential for continuous and precise insulin delivery and vital for effective blood sugar management.

The Hospital Infusion Therapy Devices Market is witnessing steady growth driven by the increasing prevalence of chronic diseases, rising surgical procedures, and advancements in infusion technologies that enhance patient safety and treatment efficiency. The hospital infusion therapy devices market continues to grow, fueled by increasing hospital admissions, demand for advanced drug delivery systems, and rising cases of chronic illnesses Alongside this, the Home Infusion Therapy Devices Market is expanding rapidly due to the growing preference for home-based care, cost-effectiveness, and patient convenience. The demand for infusion therapy devices is also bolstered by the cancer statistics published by the American Cancer Society. In 2020, there were an estimated 19.3 million new cancer cases worldwide, excluding 18.1 million cases of non-melanoma skin cancer. Breast cancer has emerged as the most commonly diagnosed cancer, comprising 11.7% of new cases, surpassing lung cancer, which accounts for 11.4% of cases. The other prevalent cancers include colorectal (10.0%), prostate (7.3%), and stomach (5.6%). Infusion therapy is integral to chemotherapy delivery, further underscoring the critical role of these devices in cancer treatment.

The infusion therapy devices market is also benefiting from increased collaborations and partnerships among industry players. For instance, in August 2023, Monidor Oy, a Finnish health technology company, partnered with B. Braun, a leading international medical device manufacturer, to enhance remote IV therapy monitoring. Such partnerships are pivotal in advancing the field of infusion therapy. In another significant development, Eitan Medical introduced a groundbreaking connected multi-therapy ambulatory infusion system, Avoset, in April 2021. Avoset is designed to transform post-acute care and specialized infusion therapy with its compact design and remote monitoring capabilities, enhancing patient safety and user experience.

The home infusion therapy devices market is expanding as patients and providers shift toward home-based treatments for convenience and cost savings. The India home infusion therapy devices market is benefiting from rapid healthcare modernization and the rising adoption of at-home care, while the South America home infusion therapy devices market is driven by improving healthcare access and growing awareness of home infusion benefits. Despite these positive trends, the market faces challenges such as the high cost of infusion therapy devices and the risk of infection associated with their use. These factors may restrain market growth during the forecast period of 2025 to 2032. However, the overall expansion of the infusion therapy device market is expected to continue, propelled by the rising need to manage chronic diseases like diabetes and cancer effectively. 

Infusion Therapy Devices Market Segment Analysis

Infusion Therapy Devices Market by Product Type (Syringe Pumps, Large Volume Pumps (LVP), Elastomeric Pumps, and Others), Mobility (Portable Infusion Pumps, and Stationary Pumps), Application (Multiple Sclerosis, Diabetes, Rheumatoid Arthritis, Cancer, and Others), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

The syringe infusion pump segment is poised to capture a substantial revenue share of the infusion therapy devices market in 2025. Known for their precision, syringe infusion pumps, or syringe drivers, are crucial for administering small volumes of fluids, such as medications or nutrients, directly into a patient’s bloodstream.

Syringe infusion pumps offer several advantages, making them indispensable in clinical settings. These devices are versatile, designed for both portable and stationary use, and incorporate an internal heater for temperature control. This feature is particularly beneficial for administering fluids that require specific temperature settings to maintain efficacy. Furthermore, syringe pumps can interface with computers, allowing healthcare providers to program the device for enhanced accuracy and to track the history of infusions, minimizing the potential for errors.

The capability to deliver fluids with higher viscosity is another notable benefit. These pumps can operate continuously for up to 24 hours, ensuring that patients receive a consistent and precise dosage of medication over a specified period. They also allow for the mixing and administering of multiple medications simultaneously, significantly reducing the need for frequent injections and improving patient comfort.

The demand for syringe infusion pumps is expected to grow due to their ability to deliver an accurate dosage over extended periods, which is increasingly essential in both acute and chronic care settings. This growth is further supported by the introduction of new and innovative products that have received regulatory approvals. For example, in August 2021, Baxter’s Novum IQ syringe infusion pump received FDA 510(k) clearance. This device enhances the infusion process with advanced safety features, improved connectivity, configurable anesthesia care settings, and a user-friendly interface, emphasizing precision and reliability in medication delivery.

Given these developments, the syringe infusion pump segment is anticipated to experience notable growth, significantly contributing to the expansion of the overall infusion therapy device market from 2025 to 2032. 

Infusion Therapy Devices Market Segmentation

Infusion Therapy Devices Market By Application

• Multiple Sclerosis
• Diabetes
• Rheumatoid Arthritis
• Cancer

Infusion Therapy Devices Market By Product Type

• Syringe Pumps
• Large Volume Pumps (LVP)
• Elastomeric Pumps
• Portable Infusion Pumps
• Stationary Pumps

Infusion Therapy Devices Market By End-User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Homecare, and Others

Infusion Therapy Devices Market by Geography

• North America Infusion Therapy Devices Market
  • United States Infusion Therapy Devices Market
  • Canada Infusion Therapy Devices Market
  • Mexico Infusion Therapy Devices Market
• Europe Infusion Therapy Devices Market
  • France Infusion Therapy Devices Market
  • Germany Infusion Therapy Devices Market
  • United Kingdom Infusion Therapy Devices Market
  • Italy Infusion Therapy Devices Market
  • Spain Infusion Therapy Devices Market
  • Russia Infusion Therapy Devices Market
  • Rest of Europe
• Asia-Pacific Infusion Therapy Devices Market
  • China Infusion Therapy Devices Market
  • Japan Infusion Therapy Devices Market
  • India Infusion Therapy Devices Market
  • Australia Infusion Therapy Devices Market
  • South Korea Infusion Therapy Devices Market
  • Rest of Asia Pacific
• Rest of the World (RoW)
  • Middle East Infusion Therapy Devices Market
  • Africa Infusion Therapy Devices Market
  • South America Infusion Therapy Devices Market

Infusion Therapy Devices Regional Insights

North America Is Expected To Dominate The Overall Infusion Therapy Devices Market

North America is projected to dominate the Infusion Therapy Devices market in 2025, buoyed by its advanced healthcare infrastructure and a high incidence of chronic diseases such as diabetes, cancer, and arthritis. The region's robust growth is further supported by continual technological advancements, the presence of major industry players, and a dynamic market environment conducive to product development and launches.

According to 2023 data from the Centers for Disease Control and Prevention (CDC), approximately 53.2 million people, or one in five U.S. adults, had doctor-diagnosed arthritis between 2019 and 2021. Arthritis is more prevalent among women (20.9%) than men (16.3%), and the likelihood of developing the condition increases with age. Notably, the prevalence of arthritis is higher among those with no leisure-time physical activity (30.9%) compared to those who are somewhat active (27.0%) or meet physical activity recommendations (18.8%). For individuals with arthritis where oral medications are ineffective, infusion therapy serves as a vital alternative, offering direct and rapid delivery of medication into the bloodstream.

The market is also stimulated by the strategic activities of leading companies based in the region, such as Mindray, Baxter, and Becton, Dickinson and Company. These firms play a critical role in the sector's growth through continuous innovation and new product offerings. For instance, in February 2023, Mindray launched its BeneFusion i and u Series infusion systems, which are notable for their high precision and user-friendly design. Featuring an intuitive full touch screen and a flat design that highlights essential parameters, the BeneFusion series enhances visibility and usability for medical staff, allowing for safer and more precise operations.

The convergence of these factors, along with ongoing product launches and regulatory approvals, underscores the significant role North America will continue to play in driving the growth of the global Infusion Therapy Devices market from 2025 to 2032. Regional trends show that the India Home Infusion Therapy Devices Market is gaining momentum with improved healthcare infrastructure and rising awareness of home healthcare solutions, while the South America Home Infusion Therapy Devices Market is also experiencing growth, supported by increasing healthcare investments and demand for accessible treatment options in remote areas.

Key Infusion Therapy Devices Companies

The following are the leading companies in the Infusion Therapy Devices market. These companies collectively hold the largest market share and dictate industry trends.

• Fresenius Kabi AG
• Ossila
• Ace-medical
• ICU Medical
• Chmyx Inc.
• Mindray
• Baxter
• Becton, Dickinson and Company
• Micrel Medical Devices SA
• AKAS Infusions
• Narang Medical Limited
• Monidor Oy
• Smiths Group plc
• B. Braun SE
• Trivitron Healthcare
• Eitan Medical
• Others

Key Infusion Therapy Devices Highlights Summary (2022–2025)

Impact Analysis

AI Advancement in Infusion Therapy Devices

• Smart Infusion Pumps with AI Integration

  • AI-enabled pumps can predict potential dosage errors and alert clinicians before administration.

  • Adaptive algorithms continuously adjust infusion rates based on patient vitals.

• Predictive Analytics for Patient Safety

  • AI models analyze patient history, medication data, and infusion patterns to predict adverse drug events.

  • Helps reduce over-infusion, under-infusion, and drug interactions.

• Closed-Loop Infusion Systems

  • AI-driven closed-loop systems connect with monitoring devices (like glucose monitors, blood pressure sensors).

  • Enables real-time automated adjustments without constant clinician intervention.

• Voice & Natural Language Command Features

  • Emerging AI features allow clinicians to control devices using voice commands, reducing manual input errors.

• Integration with Electronic Health Records (EHRs)

  • AI-powered infusion devices sync with EHRs to ensure accurate medication reconciliation.

  • Automates patient-specific infusion settings for personalized therapy.

• Remote Monitoring & Tele-Infusion

  • AI systems support IoT-enabled infusion pumps, allowing real-time monitoring outside hospitals.

  • Enhances homecare infusion therapy with automated alerts to providers.

• Anomaly Detection & Maintenance

  • AI detects device malfunctions or performance drifts early, reducing downtime and maintenance costs.

• Drug Optimization & Precision Dosing

  • AI algorithms support precision medicine by tailoring infusion dosing to individual patient metabolism.

Tariff Inclusion in Infusion Therapy Devices

The imposition of import tariffs on medical devices and components has significantly impacted the myopia treatment sector. These tariffs have led to increased costs, supply chain disruptions, and strategic shifts in manufacturing and sourcing. Understanding and navigating these changes is crucial for stakeholders aiming to maintain competitiveness and ensure uninterrupted patient care.

How This Analysis Helps Clients

• Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
• Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
• Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
• Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Startup Funding & Investment Trends: Infusion Therapy Devices Startups

Recent Developmental Activities In The Infusion Therapy Devices Market:

• ICU Medical received FDA 510(k) clearance in April 2025 for its new Plum Solo™ (single-channel) and Plum Duo™ (dual-channel) precision IV pumps, along with the LifeShield™ Infusion Safety Software. These pumps deliver medication with ±3% accuracy under real-world conditions, reducing variability and enhancing data integrity across workflows.
• Iradimed Corporation's MRidium 3870, a cutting-edge MRI-safe infusion pump, secured FDA 510(k) clearance. Deployment is expected to begin in late 2025, offering a key solution for critical care within MRI environments.
• In June 2025, the FDA issued a Class I recall for Baxter’s Novum IQ large-volume pump, involving critical updates in usage instructions due to risks of serious injury or death if misused.
• In August 2021, Baxter got the approval of U.S. Food Drug Administration (FDA) 510 (k) clearance for its Novum IQ syringe infusion pump.  
• In January 2022, ICU Medical Inc. finalized the acquisition of Smiths Medical from Smiths Group plc. This strategic move brings together a comprehensive portfolio encompassing syringe infusion devices, ambulatory infusion devices, vascular access solutions, and vital care products. By integrating the ambulatory infusion devices and vascular access offerings from Smiths Group plc with ICU Medical's Vital care products, the newly formed entity emerges as a prominent player in the infusion therapy sector, poised to exert a significant global presence.  

Key Takeaways From The Infusion Therapy Devices Market Report Study

• Market size analysis for current Infusion Therapy Devices market size (2025), and market forecast for 8 years (2025-2032)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Infusion Therapy Devices market.
• Various opportunities are available for the other competitors in the Infusion Therapy Devices market space.
• What are the top-performing segments in 2025? How these segments will perform in 2032.
• Which are the top-performing regions and countries in the current Infusion Therapy Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Infusion Therapy Devices market growth in the coming future?

Target Audience Who Can Be Benefited From This Infusion Therapy Device Market Report Study

• Infusion Therapy Devices product providers
• Research organizations and consulting companies 
• Infusion Therapy Devices organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in Infusion Therapy Devices 
• Various end-users who want to know more about the infusion therapy device market and the latest innovations and developments in the infusion therapy device market.